期刊文献+

RNA干扰靶向抑制PI3Kp85α蛋白对大肠癌细胞增值的影响 被引量:1

The Influence of Silencing PI3K p85α Expression by RNA Interference on Proliferation of Colorectal Cancer Cells
下载PDF
导出
摘要 目的:探讨RNA干扰靶向抑制PI3K p85α蛋白表达对大肠癌细胞增值的影响。方法:设计4条shRNA干扰载体及1条阴性对照载体,分别稳定转染大肠癌SW480细胞。用Western Blot筛选出一组抑制效率最高的细胞进行CCK-8细胞增值实验。结果:转染shRNA/324干扰载体的SW480细胞PI3K p85蛋白表达显著降低,抑制率约90%,选择该组细胞作为有效干扰组。CCK-8细胞增值实验显示,接种48h、72h及96h后,干扰组细胞生长速度明显低于对照组细胞(P<0.05)。结论:PI3K p85α蛋白表达缺失可降低大肠癌SW480细胞的增值速度,PI3K p85可能是大肠癌靶向治疗的新靶点。 Objective: To investigate the effect of PI3K p85α depletion via RNA interference on proliferation of colorectal cancer cells. Methods: Four shRNA vectors and one negative control vector were designed and stably transfected into SW480 cells. Western Blot analysis was used to determine the RNA interference effect of expression level of PI3K p85α protein. Cell proliferation was determined using Cell Counting Kit-8 (CCK-8) solution after stable transfection. Results. Western Blot analysis showed that the expression level of PI3K p85α protein was significantly decresed in cells transfected with shRNA/324 vector, the inhibited rate was 90%, the group was selected for the following experiments. Compared with the control cells, SW480 shRNA/324 cells grew much slowly at 48h, 72h and 96h (P〈0.05). Conclusions. Depletin of PI3K p85α could significantly inhibit proliferation of SW480 cells. PI3K p85α may be a new therapeutic target for colorectal cancer cells.
出处 《数理医药学杂志》 2009年第3期274-277,共4页 Journal of Mathematical Medicine
基金 国家自然科学基金(30300159)
关键词 大肠癌 磷脂酰肌醇3-激酶p85α亚单位 RNA干扰 细胞增值 colorectal cancer PI3K p85α RNA interference tumor metastasis cell proliferation
  • 相关文献

参考文献14

  • 1Cercek A,Saltz L B.First-line treatment of patients with metastatic colorectal cancer:an overview of recent data on chemotherapy plus targeted agents.Clin Colorectal Cancer,2008,7:S47-51.
  • 2Osaki M,Oshimura M,Ito H.PI3K-Akt pathway:Its functions and alterations in human cancer.Apoptosis,2004,9:667-676.
  • 3Philp A J,Campbell I G,Leet C,et al.The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors.Cancer Res,2001,61:7426-7429.
  • 4Tuschl T.Expanding small RNA interference.Nat Biotechnol,2002,20:446-448.
  • 5Bellacosa A,de Feo D,Godwin A K,et al.Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.Int J Cancer,1995,64:280-285.
  • 6Cheng J Q,Ruggeri B,Klein W M,et al.Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.Proc Natl Acad Sci U S A,1996,93:3636-3641.
  • 7Ringel M D,Hayre N,Saito J,et al.Overexpression and overactivation of Akt in thyroid carcinoma.Cancer Res,2001,61:6105-6111.
  • 8Cross D,Alessi D,Cohen P,et al.Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.Nature,1995;378:785-789.
  • 9Shin I,Yakes FM,Rojo F,et al.PKB/Akt mediates cell cycle progression by phosphorylation of p27kip1 at threonine 157 and modulation of its cellular localization.Nat Med,2002,8:1145-1152.
  • 10Viglietto G,Motti ML,Bruni P,et al.Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27kip1 by PKB/Akt-mediated phosphorylation in breast cancer.Nat Med,2002,8:1136-1144.

二级参考文献14

  • 1Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: Its functions and alterations in human cancer [J].Apoptosis, 2004, 9 (6): 667-76.
  • 2Carter JH, Douglass LE, Deddens JA, et al. Pak-1 expression increases with progression of colorectal carcinomas to metastasis [J]. Clin Cancer Res, 2004, 10 (10): 3448-56.
  • 3Dong Z, Huang C, Ma WY. PI-3 kinase in signal transduction, cell transformation, and as a target for chemoprevention of cancer [J]. Anticancer Res, 2001, 19 (5A): 3743-7.
  • 4Chang F, Lee JT, Navolanic PM, et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy[J]. Leukemia, 2003, 17 (3): 590-603.
  • 5Jimenez C, Jones DR, Rodriguez-Viciana P, et al. Identification and characterization of a new oneogene derived from the regulatory subunit ofphosphoinositide 3-kinase[J]. EMBO J, 1998, 17 (3): 743-53.
  • 6Philp AJ, Campbell IG, Leet C, et al. The phosphatidylinositol 3'-kinase p85 alpha gene is an oncogene in human ovarian and colon tumors[J]. Cancer Res, 2001, 61 (20): 7426-9.
  • 7Lee SH, Kim HS, Park WS, et al. Non-small cell lung cancers frequently express phosphorylated Akt; an immunohistuchemical study [J]. APMIS, 2002, 110 (7-8): 587-92.
  • 8Itoh N, Semba S, Ito M, et al, Phosphorylation of Akt/PKB is required for suppression of cancer cell apoptosis and tumor progression in human colorectal carcinoma[J]. Cancer, 2002, 94 (12): 3127-34.
  • 9Shukla S, Maclennan GT, Marengo SR, et al. Constitutive activation of PI3K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model[J]. Prostate, 2005, 64 (3): 224-39.
  • 10Saal LH, Holm K, Maurer M, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutuaUy exclusive with PTEN loss in human breast carcinoma[J]. Cancer Res, 2005, 65 (7): 2554-9.

共引文献13

同被引文献12

  • 1Hong YS, Kim TW. Chemotherapy for colorectal cancer [ J]. Korean J Gastroenterol, 2009, 54 (6): 355-363.
  • 2Falasca M. PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs [ J]. Curr Pharm Des, 2010, 16 (12): 1410-1416.
  • 3Ahn S, Kim J, Hara MR, et al.{ beta} -Arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation [J]. J Biol Chem, 2009, 284 (13): 8855-8865.
  • 4del Peso L, Gonzalez-Garcia M, Page C, et al. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt [ J]. Science, 1997, 278 (5338) : 687-689.
  • 5Sarker D, Reid AH, Yap TA, et al. Targeting the PI3K/AKT pathway for the treatment of prostate cancer [ J]. Clin Cancer Res, 2009, 15 (15) : 4799-4805.
  • 6Nicholson KM, Anderson NG. The protein kinase B/Akt signaling pathway in human malignancy [J]. Cell Signal, 2002, 14 (5) : 381- 395.
  • 7Jiang JX, Mikami K, Venugopal S, et al. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways [ J]. J Hepatol, 2009, 51 ( 1 ) : 139-148.
  • 8Lauder A, Castellanos A, Weston K. c-Myb transcription is activated by protein kinase B ( PKB ) following interleukin 2 stimulationof T cell and is required for PKB-mediated protein from apoptosis [ J]. Mol Cell Biol, 2001, 21(49): 5797-5805.
  • 9Du K, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB [J]. J Biol Chem, 1998, 273(49) : 32377-32379.
  • 10Rychahou PG, Murillo CA, Evers BM. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis inducing ligand (TRAIL) [ J]. Surgery, 2005, 138 (2) : 391-397.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部